Patients with autoimmune diseases are at high risk of COVID-19、but the medium-term effects of immunosuppression on vaccine efficacy are unknown.
Yasuhiro Kato, Atsushi Kumanogoh (Graduate School of Medicine, Osaka University/Immunopathology, IFReC), and the research group analyzed immune dynamics after vaccination against COVID-19 in patients with autoimmune diseases. They revealed some immunosuppressive therapies attenuate neutralizing antibodies against the virus.

Article (External Link)

Contact:

Atsushi Kumanogoh(Immunopathology)

Immunology Frontier Research Center, Osaka University (WPI-IFReC)